Richter Gedeon stock reports on November 10, 2026

Published on 10/15/2026 at 15:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

H1 results were published August 7, 2026. Richter Gedeon stock costs EUR 34.94 on October 15, 2026 at Lang & Schwarz.

Reporting date and price

Richter Gedeon has an earnings date of November 10, 2026.
The H1 2026 earnings presentation was published on August 7, 2026.
Richter Gedeon stock costs EUR 34.94 at Lang & Schwarz on October 15, 2026 at 3:17 p.m. CEST.
The primary listing is in Budapest under ticker RICHTER.BD.

Richter Gedeon, HU0000123096, Illustration mit AI erstellt.

Richter Gedeon (ISIN HU0000123096) has November 10, 2026 listed as its earnings date by Yahoo Finance. The next reporting date gives the stock a clear calendar marker after the company published its H1 2026 earnings presentation on August 7, 2026.

Richter Gedeon's investor page lists the H1 2026 earnings presentation among its latest reports, while its latest announcement concerns FDA submission acceptance for FYLREVY in the United States on October 14, 2026, according to Richter Gedeon. That announcement is a dated background factor rather than the central subject of this market report.

Price position in euros

The euro quotation stood at EUR 34.94 at Lang & Schwarz on October 15, 2026 at 3:17 p.m. CEST. The bid was EUR 34.68 and the ask was EUR 35.20, leaving a spread of EUR 0.52 between the displayed buying and selling prices.

The Budapest-listed share traded at HUF 12,590 on October 14, 2026, according to a market report published that day. The home-market quotation places the company in Hungary's pharmaceutical sector, while the euro quotation offers a direct view for investors following the stock through German trading venues.

Calendar and company context

The H1 2026 earnings presentation dated August 7, 2026 is the latest report listed on the investor page. The November 10, 2026 earnings date is the next calendar point identified by the cited market schedule. Richter Gedeon develops and markets pharmaceutical products, with its primary listing in Budapest under ticker RICHTER.BD.

Listing and trading view

The current euro quote provides the clearest market reference for German investors before the next reporting date. The separate Budapest quotation confirms the home-market setting and keeps the currency distinction visible.

The further course of trading is shown by the continuously updated real-time quote of Richter Gedeon stock.